Approaches to gene therapy for human immunodeficiency virus infection
- PMID: 11399224
- DOI: 10.1089/104303401750214249
Approaches to gene therapy for human immunodeficiency virus infection
Abstract
Much progress has been made in developing new and more efficient treatments for human immunodeficiency virus (HIV) infection, the cause of acquired immunodeficiency syndrome (AIDS). However, the scope of the HIV epidemic and the limitations of existing treatments necessitate the continued development of novel treatment strategies. Gene therapy is one such forward-looking strategy. Gene therapy approaches for HIV infection include efforts to interfere with viral replication directly by engineering HIV-resistant cells or indirectly by eliminating infected cells from the body, primarily by eliciting a therapeutic immune response to destroy HIV-infected cells. Although the prospect of gene therapy as a routine treatment for HIV infection remains distant, continuous progress is being made, which should also have implications for gene therapy strategies for a variety of other diseases. This article reviews some of the strategies for investigating the feasibility of gene transfer for the treatment of HIV infection.
Similar articles
-
Current developments and future prospects for HIV gene therapy using interfering RNA-based strategies.Front Biosci. 2000 May 1;5:D527-55. doi: 10.2741/lamothe. Front Biosci. 2000. PMID: 10799355 Review.
-
Progress towards gene therapy for HIV infection.Gene Ther. 1994 Jan;1(1):13-26. Gene Ther. 1994. PMID: 7584055 Review.
-
Cell therapies for treatment of human immunodeficiency virus infection.Rev Med Virol. 2015 May;25(3):156-74. doi: 10.1002/rmv.1831. Epub 2015 Mar 2. Rev Med Virol. 2015. PMID: 25727480 Review.
-
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.Hum Gene Ther. 2004 Mar;15(3):251-62. doi: 10.1089/104303404322886101. Hum Gene Ther. 2004. PMID: 15018734 Clinical Trial.
-
Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.Expert Opin Ther Targets. 2015 Feb;19(2):245-63. doi: 10.1517/14728222.2014.980236. Epub 2014 Nov 12. Expert Opin Ther Targets. 2015. PMID: 25388088 Review.
Cited by
-
Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.Mol Ther. 2012 Sep;20(9):1699-1712. doi: 10.1038/mt.2012.96. Epub 2012 May 22. Mol Ther. 2012. PMID: 22617109 Free PMC article.
-
Optimized dextran-polyethylenimine conjugates are efficient non-viral vectors with reduced cytotoxicity when used in serum containing environments.Int J Pharm. 2012 May 1;427(1):71-9. doi: 10.1016/j.ijpharm.2011.10.032. Epub 2011 Oct 21. Int J Pharm. 2012. PMID: 22037445 Free PMC article.
-
Engineering T Cells to Functionally Cure HIV-1 Infection.Mol Ther. 2015 Jul;23(7):1149-1159. doi: 10.1038/mt.2015.70. Epub 2015 Apr 21. Mol Ther. 2015. PMID: 25896251 Free PMC article. Review.
-
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency.Blood Adv. 2019 Feb 12;3(3):461-475. doi: 10.1182/bloodadvances.2018027508. Blood Adv. 2019. PMID: 30755435 Free PMC article.
-
Technologies for Targeted RNA Degradation and Induced RNA Decay.Chem Rev. 2024 Dec 11;124(23):13301-13330. doi: 10.1021/acs.chemrev.4c00472. Epub 2024 Nov 5. Chem Rev. 2024. PMID: 39499674 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical